Suboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 Diabetes

Sirois, Caroline; Moisan, Jocelyne; Poirier, Paul; Grégoire, Jean‐Pierre

doi:10.2337/dc06-2257

Cited by 9 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Control of cardiovascular risk factors, such as smoking cessation, blood pressure and cholesterol levels, is important in the management of patients with diabetes (47,48). Previous studies in Quebec (49) and elsewhere (17,44) have reported improvement in medical therapy (in-hospital and at discharge), including beta-blockers, angiotensin-converting enzyme inhibitors and hypolipidemic therapy, in patients with diabetes. Even so, these treatments were still less frequently prescribed for patients with diabetes (13).…”

Section: Figure 1) Temporal Changes In Age-and Sex-adjusted Revasculamentioning

confidence: 99%

Trends in postacute myocardial infarction management and mortality in patients with diabetes. A population-based study from 1995 to 2001

Ouhoummane

Abdous

Louchini

et al. 2010

Canadian Journal of Cardiology

Self Cite

View full text Add to dashboard Cite

Section: Figure 1) Temporal Changes In Age-and Sex-adjusted Revasculamentioning

confidence: 99%

Trends in postacute myocardial infarction management and mortality in patients with diabetes. A population-based study from 1995 to 2001

Ouhoummane

Abdous

Louchini

et al. 2010

Canadian Journal of Cardiology

Self Cite

View full text Add to dashboard Cite

“…The primary outcome will be that the patient is receiving a statin (as determined by the record of a new prescription, the record of a prescription renewal, or a notation that the patient is taking a statin). This outcome is selected because as a process of care outcome, it is closely linked to physicians' behaviour and hence is more likely to change as a result of the intervention, and because no more than one-third of patients currently receive statins, [13,22,23] so there is substantial opportunity for improvement.…”

Section: Methods and Designmentioning

confidence: 99%

Evaluation of a toolkit to improve cardiovascular disease screening and treatment for people with type 2 diabetes: protocol for a cluster-randomized pragmatic trial

Shah

Bhattacharyya

et al. 2010

Trials

View full text Add to dashboard Cite

BackgroundThe gap between the level of care recommended by evidence-based clinical practice guidelines and the actual care delivered to patients in practice has been well established. The Canadian Diabetes Association (CDA) created an implementation strategy to improve the implementation of its 2008 guidelines. This study will evaluate the impact of the strategy to improve cardiovascular disease (CVD) screening, prevention and treatment for people with diabetes.DesignA pragmatic cluster-randomized trial will be conducted to evaluate the CDA's CVD Toolkit. All family physicians in Ontario, Canada were randomly allocated to receive the Toolkit, which includes several printed educational materials targeting CVD screening, prevention and treatment, either in spring 2009 (intervention arm) or in spring 2010 (control arm). Randomization occurred at the level of the practice. Forty family physicians from each arm will be recruited to participate, and the medical records for 20 of their diabetic patients at high risk for CVD will be retrospectively reviewed. Outcome measures will be assessed for each patient between July 2009 and March 2010. The primary outcome will be that the patient is receiving a statin. Secondary outcomes will include 1) the receipt of an angiotensin converting enzyme inhibitor or angiotensin receptor blocker, 2) various intermediate measures (A1c, blood pressure, LDL-cholesterol, total-/HDL-cholesterol ratio, body mass index and waist circumference), and 3) clinical inertia (the failure to change therapy in response to an abnormal A1c, blood pressure or cholesterol reading). The analysis will be carried out using multilevel hierarchical logistic regression models to account for the clustered nature of the data. The group assignment will be a physician-level variable. In addition, a process evaluation study with six focus groups of family physicians will assess the acceptability of the CDA's Toolkit and will explore factors contributing to any change or lack of change in behaviour, from the perspectives of family physicians.DiscussionPrinted educational materials for physicians have been shown to exert small-to-moderate changes in patient care. The CDA's CVD Toolkit is an example of a practice guideline implementation strategy that can be disseminated to a wide audience relatively inexpensively, and so demonstrating its effectiveness at improving diabetes care could have important consequences for guideline developers, policy makers and clinicians.Trial RegistrationThe trial is registered with http://www.clinicaltrials.gov, ID # NCT01026688

show abstract

Current literature in diabetes

2008

Diabetes Metabolism Res

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of diabetes/metabolism. Each bibliography is divided into 26 sections: 1 Reviews; 2 General; 3 Genetics; 4 Epidemiology; 5 Immunology; 6 Obesity; 7 Prediction and Prevention; 8 Intervention: a) General; b) Care; c) Drug Therapy; d)Economics; e) Gene therapy; f) Nursing; g) Nutrition; h) Surgery; i) Transplantation; 9 Pathology and Complications: a) General; b) Cardiovascular; c) Eye disease; d) Gestational and fetal; e) Neurological; f) Podiatrical; g) Renal; 10 Endocrinology & Metabolism; 11 Experimental Studies; 12 Diagnosis and Techniques. Within each section, articles are listed in alphabetical order with respect to author

show abstract

Suboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 Diabetes

Cited by 9 publications

References 18 publications

Trends in postacute myocardial infarction management and mortality in patients with diabetes. A population-based study from 1995 to 2001

Trends in postacute myocardial infarction management and mortality in patients with diabetes. A population-based study from 1995 to 2001

Evaluation of a toolkit to improve cardiovascular disease screening and treatment for people with type 2 diabetes: protocol for a cluster-randomized pragmatic trial

Current literature in diabetes

Contact Info

Product

Resources

About